Ultragenyx Pharmaceutical Inc.'s (RARE) CEO Emil Kakkis on Q2 2020 Results - Earnings Call Transcript
Ultragenyx Pharmaceutical Inc.'s (RARE) CEO Emil Kakkis on Q2 2020 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
Ultragenyx Pharmaceutical Inc (RARE) Q2 2020 Earnings Call Transcript
RARE earnings call for the period ending June 30, 2020.
Motley Fool